For the prolonged relief of severe and intractable pain.
For the prolonged relief of severe and intractable pain, and for the relief of post-operative pain.
Mast Therapeutics has reported top-line results from EPIC, a Phase III clinical study of its investigational new drug MST 188...
The prolonged relief of severe and intractable pain.